HEALTHglobal
STAT+: U.K. to take another look at cost-effectiveness of Alzheimer’s drugs
Single source
Updated 3 hours ago
First seen March 20, 2026 20:49:27Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Following successful appeals from drugmakers, the U.K. is taking another look at whether two new Alzheimer's drugs can be considered cost-effective.